Record Number of Abstracts for LALCA 2014 Submitted.
Contact: Rob Mansheim
IASLC Director of Communications
FOR IMMEDIATE RELEASE
DENVER – The International Association for the Study of Lung Cancer (IASLC) is pleased to announce that there have been a record number of scientific abstracts for the 6th Latin American Conference on Lung Cancer (LALCA). With 151 submissions, this looks to be a great conference for science and education in Latin America.
Topics range from screening, molecular testing, and smoking cessation, just to name a few. “LALCA has been the most important meeting for lung cancer in Latin America for more than 10 years, not only because brings together oncologists from more than 21 countries but also increases awareness about lung cancer” said Luis Raez, MD, International Chair LALCA 2014.
"Lung Cancer is the most common cause of cancer deaths all over the world. After decades of no improvements in therapy, the most recent years have given significant improvements and encouragement in defined subgroups of lung cancer patients due to 'personalized’ therapy'"states Dr. Fred R. Hirsch, CEO of IASLC. "Therefore, molecular testing of tumors is crucial. Furthermore, lung cancer screening has had significant reduction in mortality. This meeting is very important in order to implement the new advances and clinical practice in Latin America."
This year marks the 6th LALCA and will be held in Lima, Peru. Previously it has been held in Brazil,
For more information on the textbook and lung cancer please visit www.iaslc.org.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association’s membership includes more than 3,800 lung cancer specialists in 80 countries. To learn more about IASLC please visit http://www.iaslc.org/